Literature DB >> 20000735

Through the "gatekeeper door": exploiting the active kinase conformation.

Fabio Zuccotto1, Elena Ardini, Elena Casale, Mauro Angiolini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20000735     DOI： 10.1021/jm901443h

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  99 in total

1.  A combinatorial in silico and cellular approach to identify a new class of compounds that target VEGFR2 receptor tyrosine kinase activity and angiogenesis.

Authors:  J Kankanala; A M Latham; A P Johnson; S Homer-Vanniasinkam; C W G Fishwick; S Ponnambalam
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  The generation of purinome-targeted libraries as a means to diversify ATP-mimetic chemical classes for lead finding.

Authors:  Eduard R Felder; Alessandra Badari; Teresa Disingrini; Sergio Mantegani; Christian Orrenius; Nilla Avanzi; Antonella Isacchi; Barbara Salom
Journal:  Mol Divers       Date:  2012-02-15       Impact factor: 2.943

3.  Structural determinants of PERK inhibitor potency and selectivity.

Authors:  Hong Wang; Jaime Blais; David Ron; Timothy Cardozo
Journal:  Chem Biol Drug Des       Date:  2010-12       Impact factor: 2.817

4.  Computational Modeling of Kinase Inhibitor Selectivity.

Authors:  Govindan Subramanian; Manish Sud
Journal:  ACS Med Chem Lett       Date:  2010-07-28       Impact factor: 4.345

Review 5.  Protein kinases: evolution of dynamic regulatory proteins.

Authors:  Susan S Taylor; Alexandr P Kornev
Journal:  Trends Biochem Sci       Date:  2010-10-23       Impact factor: 13.807

6.  (R)-2-Phenylpyrrolidine Substituted Imidazopyridazines: A New Class of Potent and Selective Pan-TRK Inhibitors.

Authors:  Ha-Soon Choi; Paul V Rucker; Zhicheng Wang; Yi Fan; Pamela Albaugh; Greg Chopiuk; Francois Gessier; Fangxian Sun; Francisco Adrian; Guoxun Liu; Tami Hood; Nanxin Li; Yong Jia; Jianwei Che; Susan McCormack; Allen Li; Jie Li; Auzon Steffy; AnneMarie Culazzo; Celine Tompkins; Van Phung; Andreas Kreusch; Min Lu; Bin Hu; Apurva Chaudhary; Mahavir Prashad; Tove Tuntland; Bo Liu; Jennifer Harris; H Martin Seidel; Jon Loren; Valentina Molteni
Journal:  ACS Med Chem Lett       Date:  2015-03-16       Impact factor: 4.345

7.  Kinome-wide activity modeling from diverse public high-quality data sets.

Authors:  Stephan C Schürer; Steven M Muskal
Journal:  J Chem Inf Model       Date:  2013-01-09       Impact factor: 4.956

8.  The human kinome and kinase inhibition.

Authors:  Krisna C Duong-Ly; Jeffrey R Peterson
Journal:  Curr Protoc Pharmacol       Date:  2013-03

9.  Discovery of biarylaminoquinazolines as novel tubulin polymerization inhibitors.

Authors:  Giovanni Marzaro; Antonio Coluccia; Alessandro Ferrarese; Paola Brun; Ignazio Castagliuolo; Maria Teresa Conconi; Giuseppe La Regina; Ruoli Bai; Romano Silvestri; Ernest Hamel; Adriana Chilin
Journal:  J Med Chem       Date:  2014-05-14       Impact factor: 7.446

Review 10.  Clinical potential of pacritinib in the treatment of myelofibrosis.

Authors:  Ana B Duenas-Perez; Adam J Mead
Journal:  Ther Adv Hematol       Date:  2015-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.